Sempra (SRE)

Investing Cash Flow

-$16.09B

TTM · Period ending: · USD

SRE logo

SRE Investing Cash Flow

Latest reported-$16.09B
SRE TTM Cash from Investing (-$247.40M → -$16.09B)
High-resolution chart · PNG

SRE investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Sempra Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-16,090,000,000
-16,015,000,000
-15,530,000,000
-11,398,000,000
-10,513,000,000
-9,796,000,000
-9,118,000,000
-8,708,000,000
-8,463,000,000
-8,928,000,000
-8,716,000,000
-8,160,000,000
-6,925,000,000
-5,644,000,000
-5,039,000,000
-5,235,000,000
-5,455,000,000
-5,497,000,000
-5,508,000,000
-5,318,000,000
-4,889,000,000
433,000,000
553,000,000
1,261,000,000
528,000,000
-5,774,000,000
-5,203,000,000
-3,902,000,000
-3,782,000,000
-13,332,000,000
-23,424,000,000
-25,011,000,000
-25,152,000,000
-14,367,000,000
-4,691,000,000
-4,654,000,000
-5,300,000,000
-4,872,000,000
-4,835,000,000
-4,338,000,000
-3,277,000,000
-3,104,000,000
-2,885,000,000
-2,855,000,000
-2,922,000,000
-3,342,000,000
-3,342,000,000
-3,254,000,000
-2,683,000,000
-2,297,000,000
-1,689,000,000
-1,483,000,000
-2,004,000,000
-2,461,000,000
-3,158,000,000
-3,342,000,000
-3,198,000,000
-3,173,000,000
-3,070,000,000
-2,954,000,000
-1,769,000,000
-1,543,000,000
-1,283,000,000
-1,335,000,000
-2,852,000,000
-2,646,000,000
-2,672,000,000
-2,760,000,000
-2,215,000,000
-1,799,000,000
-2,386,000,000
-2,326,000,000
-2,352,000,000
-2,782,000,000
-2,073,000,000
-1,866,000,000
-1,391,000,000
-760,000,000
-865,000,000
-805,000,000
-1,004,000,000
-1,444,000,000
-1,185,000,000
-987,000,000
-1,105,000,000
-954,000,000
-559,000,000
-660,000,000
-602,000,000
-832,000,000
-1,253,000,000
-1,388,000,000
-1,539,000,000
-1,644,000,000
-1,659,000,000
-1,600,000,000
-1,527,000,000
-1,242,000,000
-1,039,000,000
-991,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.